🌐 WorldLive
Accueil › 🇬🇧 Royaume-Uni › Science

Glubio Therapeutics’ GLB-005 included in rare disease pilot program in China

Glubio Therapeutics’ GLB-005 included in rare disease pilot program in China

Glubio Therapeutics Inc.’s WIZ (widely interspaced zinc finger) molecular glue degrader GLB-005 has been included in China’s Center for Drug Evaluation’s (CDE) Patient-Centered Action for Rare Diseases Encouragement (CARE) plan.